Golrang Pharmaceutical Investment(GPI) Human Capital Report

Faran Shimi

As one of the knowledge-based companies in Iran, Faran Shimi Pharmaceutical Company was established in 2002, aiming to produce raw materials and narcotic medicines.
This company became operational in 2010, with the focus on the production of narcotic finish products and APIs as one of the affiliate companies to Golrang Pharmaceutical Holding.
Among the main activities of Faran Shimi Company, are the production of specialized medicines such as Migusca, Bosentan, Fampiron, Metformin and the production of APIs, including Sitagliptin phosphate, Empagliflozin, Bosentan Monohydrate, Buprenorphine Hydrochloride, Apixaban, etc. can be pointed out.
The main objective of the company is to produce new and innovative products with the aim of improving the quality of people's lives in line to promote the health of the society.